(-)-demecolcine increases expression ISO DOCK4 (Homo sapiens) 6480464 Demecolcine results in increased expression of DOCK4 mRNA CTD PMID:23649840 (1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DOCK4 mRNA CTD PMID:36331819 17alpha-ethynylestradiol increases expression ISO Dock4 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in increased expression of DOCK4 mRNA CTD PMID:29097150 17beta-estradiol multiple interactions ISO DOCK4 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of DOCK4 mRNA CTD PMID:30165855 17beta-estradiol increases expression ISO Dock4 (Rattus norvegicus) 6480464 Estradiol results in increased expression of DOCK4 mRNA CTD PMID:32145629 17beta-estradiol multiple interactions ISO Dock4 (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DOCK4 mRNA and [Testosterone co-treated with Estradiol] results in increased expression of DOCK4 mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions ISO Dock4 (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DOCK4 mRNA CTD PMID:32741896 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO DOCK4 (Homo sapiens) 6480464 Dihydrotestosterone results in increased expression of DOCK4 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of DOCK4 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Dock4 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of DOCK4 mRNA CTD PMID:32109520 and PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of DOCK4 mRNA CTD PMID:19465110 and PMID:26290441 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO Dock4 (Rattus norvegicus) 6480464 2 more ... CTD PMID:32109520 acrolein multiple interactions ISO DOCK4 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DOCK4 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DOCK4 mRNA CTD PMID:32699268 aflatoxin B1 affects expression ISO DOCK4 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of DOCK4 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO DOCK4 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of DOCK4 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO DOCK4 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of DOCK4 mRNA CTD PMID:22100608 aflatoxin B1 increases expression ISO DOCK4 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of DOCK4 mRNA CTD PMID:21641981 all-trans-retinoic acid increases expression ISO DOCK4 (Homo sapiens) 6480464 Tretinoin results in increased expression of DOCK4 mRNA CTD PMID:21934132 and PMID:33167477 alpha-pinene multiple interactions ISO DOCK4 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DOCK4 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DOCK4 mRNA CTD PMID:32699268 antirheumatic drug increases expression ISO DOCK4 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of DOCK4 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO DOCK4 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of DOCK4 mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO DOCK4 (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to DOCK4 mRNA] CTD PMID:32406909 atrazine decreases expression ISO Dock4 (Rattus norvegicus) 6480464 Atrazine results in decreased expression of DOCK4 mRNA CTD PMID:36841081 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of DOCK4 mRNA CTD PMID:19770486 and PMID:21569818 benzo[a]pyrene affects methylation ISO DOCK4 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of DOCK4 exon CTD PMID:30157460 benzo[a]pyrene decreases expression ISO DOCK4 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of DOCK4 mRNA CTD PMID:20064835 more ... benzo[a]pyrene affects expression ISO DOCK4 (Homo sapiens) 6480464 Benzo(a)pyrene affects the expression of DOCK4 mRNA CTD PMID:21714911 benzo[a]pyrene diol epoxide I decreases expression ISO DOCK4 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 and PMID:26238291 benzo[e]pyrene decreases methylation ISO DOCK4 (Homo sapiens) 6480464 benzo(e)pyrene results in decreased methylation of DOCK4 intron CTD PMID:30157460 bisphenol A increases expression ISO Dock4 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of DOCK4 mRNA CTD PMID:29097150 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of DOCK4 mRNA CTD PMID:35598803 bisphenol A decreases expression ISO Dock4 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of DOCK4 mRNA CTD PMID:34947998 bisphenol A increases expression ISO DOCK4 (Homo sapiens) 6480464 bisphenol A results in increased expression of DOCK4 mRNA CTD PMID:29275510 and PMID:36232920 bisphenol F increases methylation ISO DOCK4 (Homo sapiens) 6480464 bisphenol F results in increased methylation of DOCK4 gene CTD PMID:31601247 caffeine affects phosphorylation ISO DOCK4 (Homo sapiens) 6480464 Caffeine affects the phosphorylation of DOCK4 protein CTD PMID:35688186 calcitriol increases expression ISO DOCK4 (Homo sapiens) 6480464 Calcitriol results in increased expression of DOCK4 mRNA CTD PMID:16002434 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of DOCK4 mRNA CTD PMID:23125180 chloroprene increases expression ISO Dock4 (Rattus norvegicus) 6480464 Chloroprene results in increased expression of DOCK4 mRNA CTD PMID:23125180 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of DOCK4 mRNA CTD PMID:37019170 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of DOCK4 mRNA CTD PMID:20938992 cisplatin multiple interactions ISO DOCK4 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of DOCK4 mRNA CTD PMID:27392435 crocidolite asbestos increases expression ISO DOCK4 (Homo sapiens) 6480464 Asbestos and Crocidolite results in increased expression of DOCK4 mRNA CTD PMID:18687144 Cuprizon decreases expression ISO Dock4 (Rattus norvegicus) 6480464 Cuprizone results in decreased expression of DOCK4 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO DOCK4 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of DOCK4 mRNA CTD PMID:25562108 and PMID:27989131 diazinon increases methylation ISO DOCK4 (Homo sapiens) 6480464 Diazinon results in increased methylation of DOCK4 gene CTD PMID:22964155 diquat increases expression EXP 6480464 Diquat results in increased expression of DOCK4 protein CTD PMID:36851058 disodium selenite decreases expression ISO DOCK4 (Homo sapiens) 6480464 Sodium Selenite results in decreased expression of DOCK4 mRNA CTD PMID:18175754 dorsomorphin multiple interactions ISO DOCK4 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects response to substance ISO DOCK4 (Homo sapiens) 6480464 DOCK4 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin decreases expression ISO DOCK4 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of DOCK4 mRNA CTD PMID:29803840 endosulfan decreases expression ISO Dock4 (Rattus norvegicus) 6480464 Endosulfan results in decreased expression of DOCK4 mRNA CTD PMID:29391264 ethanol affects splicing EXP 6480464 Ethanol affects the splicing of DOCK4 mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO DOCK4 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of DOCK4 mRNA CTD PMID:23649840 flutamide decreases expression ISO Dock4 (Rattus norvegicus) 6480464 Flutamide results in decreased expression of DOCK4 mRNA CTD PMID:24793618 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of DOCK4 mRNA CTD PMID:20938992 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of DOCK4 mRNA CTD PMID:25629700 FR900359 affects phosphorylation ISO DOCK4 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of DOCK4 protein CTD PMID:37730182 hydrogen peroxide multiple interactions ISO DOCK4 (Homo sapiens) 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in increased expression of DOCK4 protein CTD PMID:18951874 ivermectin decreases expression ISO DOCK4 (Homo sapiens) 6480464 Ivermectin results in decreased expression of DOCK4 protein CTD PMID:32959892 kojic acid increases expression ISO DOCK4 (Homo sapiens) 6480464 kojic acid results in increased expression of DOCK4 mRNA CTD PMID:16595896 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of DOCK4 mRNA CTD PMID:20938992 lead diacetate multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in decreased methylation of DOCK4 intron CTD PMID:33445541 lead(0) multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in decreased methylation of DOCK4 intron CTD PMID:33445541 methapyrilene decreases methylation ISO DOCK4 (Homo sapiens) 6480464 Methapyrilene results in decreased methylation of DOCK4 intron CTD PMID:30157460 methoxychlor affects methylation ISO Dock4 (Rattus norvegicus) 6480464 Methoxychlor affects the methylation of DOCK4 gene CTD PMID:35440735 methylmercury chloride decreases expression ISO DOCK4 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of DOCK4 mRNA CTD PMID:28001369 mono(2-ethylhexyl) phthalate increases expression ISO DOCK4 (Homo sapiens) 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of DOCK4 mRNA CTD PMID:36695872 N,N-diethyl-m-toluamide multiple interactions ISO Dock4 (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in decreased methylation of DOCK4 gene CTD PMID:33148267 ozone multiple interactions ISO DOCK4 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DOCK4 mRNA more ... CTD PMID:32699268 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of DOCK4 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of DOCK4 mRNA CTD PMID:27106289 and PMID:34911549 PD 0325901 multiple interactions ISO DOCK4 (Homo sapiens) 6480464 [mirdametinib co-treated with (+)-JQ1 compound] results in decreased expression of DOCK4 mRNA CTD PMID:25119042 PD 0325901 decreases expression ISO DOCK4 (Homo sapiens) 6480464 mirdametinib results in decreased expression of DOCK4 mRNA CTD PMID:25119042 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DOCK4 mRNA CTD PMID:36331819 permethrin multiple interactions ISO Dock4 (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in decreased methylation of DOCK4 gene CTD PMID:33148267 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of DOCK4 mRNA CTD PMID:19270015 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of DOCK4 mRNA CTD PMID:23091169 pirinixic acid multiple interactions ISO DOCK4 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DOCK4 mRNA CTD PMID:19710929 potassium chromate decreases expression ISO DOCK4 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of DOCK4 mRNA CTD PMID:22714537 potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of DOCK4 mRNA CTD PMID:23608068 progesterone decreases expression ISO DOCK4 (Homo sapiens) 6480464 Progesterone results in decreased expression of DOCK4 mRNA CTD PMID:21795739 propanal increases expression ISO DOCK4 (Homo sapiens) 6480464 propionaldehyde results in increased expression of DOCK4 mRNA CTD PMID:26079696 quercetin decreases expression ISO DOCK4 (Homo sapiens) 6480464 Quercetin results in decreased expression of DOCK4 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO DOCK4 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of DOCK4 mRNA CTD PMID:23557933 rotenone increases expression ISO Dock4 (Rattus norvegicus) 6480464 Rotenone results in increased expression of DOCK4 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO DOCK4 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO DOCK4 (Homo sapiens) 6480464 Silicon Dioxide results in increased expression of DOCK4 mRNA CTD PMID:25351596 sodium dichromate decreases expression ISO DOCK4 (Homo sapiens) 6480464 sodium bichromate results in decreased expression of DOCK4 mRNA CTD PMID:17685462 sulforaphane decreases expression ISO DOCK4 (Homo sapiens) 6480464 sulforaphane results in decreased expression of DOCK4 mRNA CTD PMID:31838189 tert-butyl hydroperoxide increases expression ISO DOCK4 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased expression of DOCK4 mRNA CTD PMID:15336504 testosterone multiple interactions ISO Dock4 (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DOCK4 mRNA and [Testosterone co-treated with Estradiol] results in increased expression of DOCK4 mRNA CTD PMID:32741896 theophylline multiple interactions ISO DOCK4 (Homo sapiens) 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in increased expression of DOCK4 protein CTD PMID:18951874 thimerosal increases expression ISO DOCK4 (Homo sapiens) 6480464 Thimerosal results in increased expression of DOCK4 mRNA CTD PMID:27188386 thioacetamide decreases expression ISO Dock4 (Rattus norvegicus) 6480464 Thioacetamide results in decreased expression of DOCK4 mRNA CTD PMID:34492290 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of DOCK4 mRNA CTD PMID:23557971 trichostatin A increases expression ISO DOCK4 (Homo sapiens) 6480464 trichostatin A results in increased expression of DOCK4 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO DOCK4 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DOCK4 mRNA CTD PMID:27188386 valproic acid affects expression ISO DOCK4 (Homo sapiens) 6480464 Valproic Acid affects the expression of DOCK4 mRNA CTD PMID:25979313 valproic acid increases expression ISO DOCK4 (Homo sapiens) 6480464 Valproic Acid results in increased expression of DOCK4 mRNA CTD PMID:26272509 and PMID:29154799 valproic acid multiple interactions ISO DOCK4 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DOCK4 mRNA CTD PMID:27188386 vincristine increases expression ISO DOCK4 (Homo sapiens) 6480464 Vincristine results in increased expression of DOCK4 mRNA CTD PMID:23649840 vorinostat increases expression ISO DOCK4 (Homo sapiens) 6480464 vorinostat results in increased expression of DOCK4 mRNA CTD PMID:26272509 vorinostat multiple interactions ISO DOCK4 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DOCK4 mRNA CTD PMID:27188386